CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: farnesoid X receptor agonist
Accession: CHEBI:132972
browse the term
Definition: An agonist that binds to and activates farnesoid X receptors
Synonyms: related_synonym: BAR agonist; BAR agonists; FXR agonist; FXR agonists; bile acid receptor agonist; bile acid receptor agonists; farnesoid X receptor agonists
xref: Wikipedia:Farnesoid_X_receptor
G
A2m
alpha-2-macroglobulin
decreases expression
ISO
obeticholic acid results in decreased expression of A2M mRNA
CTD
PMID:27939613
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
G
Abca1
ATP binding cassette subfamily A member 1
decreases expression
ISO
obeticholic acid results in decreased expression of ABCA1 mRNA
CTD
PMID:27939613
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions increases expression
ISO EXP
obeticholic acid promotes the reaction [PRMT1 protein binds to ABCB11 promoter] obeticholic acid results in increased expression of ABCB11 mRNA obeticholic acid inhibits the reaction [Isoniazid results in decreased expression of ABCB11 mRNA]; obeticholic acid inhibits the reaction [Pyrazinamide results in decreased expression of ABCB11 mRNA] [obeticholic acid co-treated with 1-Naphthylisothiocyanate] results in increased expression of ABCB11 protein; obeticholic acid inhibits the reaction [[triptolide co-treated with Lipopolysaccharides] results in decreased expression of ABCB11 protein]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 mRNA]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 protein] Obeticholic acid inhibits the reaction [ethanol decreases expression of Abcb11 protein in liver]
CTD RGD
PMID:15644430 PMID:15911693 PMID:27255380 PMID:27939613 PMID:29660435 PMID:32673658 PMID:36328986 PMID:36787806 PMID:27939985 More...
RGD:15036816
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcb4
ATP binding cassette subfamily B member 4
multiple interactions increases expression
EXP ISO
obeticholic acid inhibits the reaction [Pyrazinamide results in decreased expression of ABCB4 mRNA] obeticholic acid results in increased expression of ABCB4 mRNA
CTD
PMID:15644430 PMID:27255380 PMID:27939613
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
G
Abcc2
ATP binding cassette subfamily C member 2
multiple interactions increases expression
EXP ISO
obeticholic acid inhibits the reaction [Pyrazinamide results in decreased expression of ABCC2 mRNA] obeticholic acid results in increased expression of ABCC2 mRNA [obeticholic acid co-treated with 1-Naphthylisothiocyanate] results in increased expression of ABCC2 protein; [triptolide co-treated with Lipopolysaccharides co-treated with obeticholic acid] results in increased expression of ABCC2 mRNA; NR1H4 promotes the reaction [obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 mRNA]]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 mRNA]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 protein]
CTD
PMID:15644430 PMID:27255380 PMID:29660435 PMID:36328986 PMID:36787806
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcc3
ATP binding cassette subfamily C member 3
multiple interactions
EXP ISO
obeticholic acid inhibits the reaction [Isoniazid results in decreased expression of ABCC3 mRNA] [obeticholic acid co-treated with 1-Naphthylisothiocyanate] results in increased expression of ABCC3 protein
CTD
PMID:32673658 PMID:36787806
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
G
Abcc4
ATP binding cassette subfamily C member 4
multiple interactions
ISO
[obeticholic acid co-treated with 1-Naphthylisothiocyanate] results in increased expression of ABCC4 protein
CTD
PMID:36787806
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
G
Abcg1
ATP binding cassette subfamily G member 1
decreases expression
ISO
obeticholic acid results in decreased expression of ABCG1 mRNA
CTD
PMID:27939613
NCBI chr20:9,126,687...9,182,948
Ensembl chr20:9,126,687...9,182,948
G
Acaa1a
acetyl-CoA acyltransferase 1A
increases expression
ISO
obeticholic acid results in increased expression of ACAA1 mRNA
CTD
PMID:27939613
NCBI chr 8:119,079,401...119,088,626
Ensembl chr 8:119,079,775...119,088,624
G
Acaa2
acetyl-CoA acyltransferase 2
increases expression
ISO
obeticholic acid results in increased expression of ACAA2 mRNA
CTD
PMID:27939613
NCBI chr18:68,345,136...68,373,246
Ensembl chr18:68,345,012...68,373,249
G
Acaca
acetyl-CoA carboxylase alpha
decreases expression
ISO
obeticholic acid results in decreased expression of ACACA mRNA
CTD
PMID:27939613
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
G
Acot9
acyl-CoA thioesterase 9
increases expression
ISO
obeticholic acid results in increased expression of ACOT9 mRNA
CTD
PMID:27939613
NCBI chr X:40,073,197...40,123,573
Ensembl chr X:40,064,810...40,123,559
G
Acox1
acyl-CoA oxidase 1
increases expression
ISO
obeticholic acid results in increased expression of ACOX1 mRNA
CTD
PMID:26655953 PMID:27939613
NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232
G
Acox2
acyl-CoA oxidase 2
increases expression
ISO
obeticholic acid results in increased expression of ACOX2 mRNA
CTD
PMID:27939613
NCBI chr15:16,660,584...16,692,160
Ensembl chr15:16,660,272...16,692,160
G
Acox3
acyl-CoA oxidase 3, pristanoyl
increases expression
ISO
obeticholic acid results in increased expression of ACOX3 mRNA
CTD
PMID:27939613
NCBI chr14:75,133,986...75,176,767
Ensembl chr14:75,094,676...75,176,205
G
Acsl1
acyl-CoA synthetase long-chain family member 1
decreases expression
ISO
obeticholic acid results in decreased expression of ACSL1 mRNA
CTD
PMID:27939613
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
G
Acsl4
acyl-CoA synthetase long-chain family member 4
increases expression
ISO
obeticholic acid results in increased expression of ACSL4 mRNA
CTD
PMID:27939613
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
G
Acsl5
acyl-CoA synthetase long-chain family member 5
increases expression
ISO
obeticholic acid results in increased expression of ACSL5 mRNA
CTD
PMID:27939613
NCBI chr 1:254,289,513...254,336,608
Ensembl chr 1:254,292,521...254,336,607
G
Acsl6
acyl-CoA synthetase long-chain family member 6
increases expression
ISO
obeticholic acid results in increased expression of ACSL6 mRNA
CTD
PMID:27939613
NCBI chr10:38,439,914...38,501,182
Ensembl chr10:38,440,080...38,498,757
G
Adamtsl2
ADAMTS-like 2
decreases expression
ISO
obeticholic acid results in decreased expression of ADAMTSL2 mRNA
CTD
PMID:27939613
NCBI chr 3:10,397,774...10,434,557
Ensembl chr 3:10,404,626...10,434,554
G
Adcy1
adenylate cyclase 1
increases expression
ISO
obeticholic acid results in increased expression of ADCY1 mRNA
CTD
PMID:27939613
NCBI chr14:81,911,240...82,020,594
Ensembl chr14:81,911,099...82,028,969
G
Adh1c
alcohol dehydrogenase 1C (class I), gamma polypeptide
decreases expression
ISO
obeticholic acid results in decreased expression of ADH1C mRNA
CTD
PMID:27939613
NCBI chr 2:226,797,303...226,808,892
Ensembl chr 2:226,797,303...226,808,892
G
Agpat2
1-acylglycerol-3-phosphate O-acyltransferase 2
decreases expression
ISO
obeticholic acid results in decreased expression of AGPAT2 mRNA
CTD
PMID:27939613
NCBI chr 3:9,416,837...9,428,567
Ensembl chr 3:9,416,843...9,428,371
G
Agpat5
1-acylglycerol-3-phosphate O-acyltransferase 5
decreases expression
ISO
obeticholic acid results in decreased expression of AGPAT5 mRNA
CTD
PMID:27939613
NCBI chr16:70,939,480...70,985,745
Ensembl chr16:70,943,135...70,985,560
G
Akr1d1
aldo-keto reductase family 1, member D1
decreases expression
ISO
obeticholic acid results in decreased expression of AKR1D1 mRNA
CTD
PMID:27939613
NCBI chr 4:66,154,246...66,187,505
Ensembl chr 4:66,154,248...66,186,372
G
Akt1
AKT serine/threonine kinase 1
multiple interactions decreases expression decreases phosphorylation
ISO
obeticholic acid inhibits the reaction [Carbon Tetrachloride results in increased phosphorylation of AKT1 protein]; obeticholic acid promotes the reaction [Dietary Fats results in decreased phosphorylation of AKT1 protein] obeticholic acid results in decreased expression of AKT1 mRNA obeticholic acid results in decreased phosphorylation of AKT1 protein
CTD
PMID:27865854 PMID:27939613 PMID:35267068
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Akt2
AKT serine/threonine kinase 2
decreases expression
ISO
obeticholic acid results in decreased expression of AKT2 mRNA
CTD
PMID:27939613
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
G
Alb
albumin
decreases expression multiple interactions
ISO EXP
obeticholic acid results in decreased expression of ALB mRNA [Dietary Fats co-treated with obeticholic acid] results in decreased expression of ALB mRNA; [Dietary Fats co-treated with obeticholic acid] results in decreased expression of ALB protein
CTD
PMID:27939613 PMID:35267068
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Aldoa
aldolase, fructose-bisphosphate A
decreases expression
ISO
obeticholic acid results in decreased expression of ALDOA mRNA
CTD
PMID:27939613
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
G
Aldob
aldolase, fructose-bisphosphate B
decreases expression
ISO
obeticholic acid results in decreased expression of ALDOB mRNA
CTD
PMID:27939613
NCBI chr 5:63,889,045...63,902,086
Ensembl chr 5:63,889,046...63,902,116
G
Aldoc
aldolase, fructose-bisphosphate C
increases expression
ISO
obeticholic acid results in increased expression of ALDOC mRNA
CTD
PMID:27939613
NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066
G
Amn
amnion associated transmembrane protein
decreases expression
ISO
obeticholic acid results in decreased expression of AMN mRNA
CTD
PMID:27939613
NCBI chr 6:130,311,372...130,318,815
Ensembl chr 6:130,311,372...130,318,815
G
Apoa1
apolipoprotein A1
decreases expression
ISO
obeticholic acid results in decreased expression of APOA1 mRNA
CTD
PMID:27939613
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
G
Apoa2
apolipoprotein A2
increases expression
ISO
obeticholic acid results in increased expression of APOA2 mRNA
CTD
PMID:27939613
NCBI chr13:83,644,460...83,646,358
Ensembl chr13:83,644,470...83,646,355
G
Apob
apolipoprotein B
increases expression
ISO
obeticholic acid results in increased expression of APOB mRNA
CTD
PMID:27939613
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
G
Apoc2
apolipoprotein C2
increases expression
ISO
obeticholic acid results in increased expression of APOC2 mRNA
CTD
PMID:27939613
NCBI chr 1:79,329,429...79,334,397
Ensembl chr 1:79,329,428...79,334,476
G
Apoc3
apolipoprotein C3
decreases expression
ISO
obeticholic acid results in decreased expression of APOC3 mRNA
CTD
PMID:27939613
NCBI chr 8:46,531,478...46,533,658
Ensembl chr 8:46,531,478...46,533,583
G
Apoe
apolipoprotein E
decreases expression
ISO
obeticholic acid results in decreased expression of APOE mRNA
CTD
PMID:27939613
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
G
Aspg
asparaginase
decreases expression
ISO
obeticholic acid results in decreased expression of ASPG mRNA
CTD
PMID:27939613
NCBI chr 6:131,176,727...131,196,268
Ensembl chr 6:131,176,874...131,196,268
G
Atg5
autophagy related 5
multiple interactions
ISO
obeticholic acid inhibits the reaction [[Dietary Fats co-treated with Dextran Sulfate] results in decreased expression of ATG5 mRNA]
CTD
PMID:35439472
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
G
Bad
BCL2-associated agonist of cell death
decreases expression
ISO
obeticholic acid results in decreased expression of BAD mRNA
CTD
PMID:27939613
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
G
Bcl2
BCL2, apoptosis regulator
increases expression multiple interactions
ISO
obeticholic acid results in increased expression of BCL2 mRNA [Dietary Fats co-treated with obeticholic acid] results in decreased expression of BCL2 protein
CTD
PMID:27939613 PMID:35267068
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bid
BH3 interacting domain death agonist
decreases expression
ISO
obeticholic acid results in decreased expression of BID mRNA
CTD
PMID:27939613
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
G
Birc3
baculoviral IAP repeat-containing 3
decreases expression
ISO
obeticholic acid results in decreased expression of BIRC3 mRNA
CTD
PMID:27939613
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
G
C5ar2
complement C5a receptor 2
decreases expression
ISO
obeticholic acid results in decreased expression of C5AR2 mRNA
CTD
PMID:27939613
NCBI chr 1:76,930,381...76,945,432
Ensembl chr 1:76,930,383...76,959,517
G
Car14
carbonic anhydrase 14
increases expression
ISO
obeticholic acid results in increased expression of CA14 mRNA
CTD
PMID:27939613
NCBI chr 2:183,442,263...183,449,231
Ensembl chr 2:183,441,667...183,449,693
G
Casp3
caspase 3
multiple interactions
EXP ISO
obeticholic acid promotes the reaction [Cycloheximide results in increased activity of CASP3 protein] obeticholic acid inhibits the reaction [Dietary Fats results in increased expression of CASP3 protein]
CTD
PMID:15860571 PMID:26655953
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp4
caspase 4
multiple interactions
ISO
obeticholic acid inhibits the reaction [[triptolide co-treated with Lipopolysaccharides] results in increased cleavage of CASP4 protein]
CTD
PMID:36328986
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
G
Casp8
caspase 8
increases expression
ISO
obeticholic acid results in increased expression of CASP8 mRNA
CTD
PMID:27939613
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
ISO
obeticholic acid inhibits the reaction [Carbon Tetrachloride results in increased expression of CCL2 mRNA]
CTD
PMID:27865854
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccnb1
cyclin B1
multiple interactions
ISO
obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCNB1 protein]
CTD
PMID:29660435
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
G
Ccnd1
cyclin D1
multiple interactions
ISO
obeticholic acid inhibits the reaction [[Dietary Fats co-treated with Dextran Sulfate] results in decreased expression of CCND1 protein]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCND1 protein]
CTD
PMID:29660435 PMID:35439472
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccs
copper chaperone for superoxide dismutase
decreases expression
ISO
obeticholic acid results in decreased expression of CCS mRNA
CTD
PMID:27939613
NCBI chr 1:202,113,792...202,134,931
Ensembl chr 1:202,113,804...202,134,915
G
Cd14
CD14 molecule
decreases expression
ISO
obeticholic acid results in decreased expression of CD14 mRNA
CTD
PMID:27939613
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
G
Cldn5
claudin 5
multiple interactions
ISO
obeticholic acid inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 protein]
CTD
PMID:36720452
NCBI chr11:82,212,822...82,214,248
Ensembl chr11:82,211,475...82,214,992
G
Clic4
chloride intracellular channel 4
increases expression
ISO
obeticholic acid results in increased expression of CLIC4 mRNA
CTD
PMID:27939613
NCBI chr 5:147,453,702...147,513,455
Ensembl chr 5:147,453,712...147,513,452
G
Col1a1
collagen type I alpha 1 chain
decreases expression multiple interactions
EXP ISO
obeticholic acid results in decreased expression of COL1A1 mRNA; obeticholic acid results in decreased expression of COL1A1 protein obeticholic acid inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA] obeticholic acid inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of COL1A1 mRNA]
CTD
PMID:15860571 PMID:15980055 PMID:27939613 PMID:30745416
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Cpt1a
carnitine palmitoyltransferase 1A
multiple interactions increases expression
ISO EXP
obeticholic acid promotes the reaction [Palmitic Acid results in increased expression of CPT1A mRNA] obeticholic acid results in increased expression of CPT1A mRNA obeticholic acid inhibits the reaction [Ethanol results in decreased expression of CPT1A protein] Obeticholic acid inhibits the reaction [ethanol decreases expression of CPT1a mRNA and protein in liver] obeticholic acid results in increased expression of CPT1A protein
CTD RGD
PMID:26655953 PMID:27939613 PMID:27939985 PMID:32738331 PMID:27939985
RGD:15036816
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
G
Cpt2
carnitine palmitoyltransferase 2
increases expression
ISO
obeticholic acid results in increased expression of CPT2 mRNA
CTD
PMID:27939613
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
G
Crct1
cysteine-rich C-terminal 1
decreases expression
ISO
obeticholic acid results in decreased expression of CRCT1 mRNA
CTD
PMID:27939613
NCBI chr 2:178,633,789...178,635,274
Ensembl chr 2:178,634,092...178,634,394
G
Creb3l1
cAMP responsive element binding protein 3-like 1
decreases expression
ISO
obeticholic acid results in decreased expression of CREB3L1 mRNA
CTD
PMID:27939613
NCBI chr 3:77,952,589...77,993,513
Ensembl chr 3:77,952,540...77,993,456
G
Creb3l3
cAMP responsive element binding protein 3-like 3
increases expression
ISO
obeticholic acid results in increased expression of CREB3L3 mRNA
CTD
PMID:27939613
NCBI chr 7:8,622,614...8,631,053
Ensembl chr 7:8,622,614...8,631,048
G
Crp
C-reactive protein
decreases expression
ISO
obeticholic acid results in decreased expression of CRP mRNA
CTD
PMID:27939613
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Cxcl2
C-X-C motif chemokine ligand 2
multiple interactions
ISO
obeticholic acid inhibits the reaction [Carbon Tetrachloride results in increased expression of CXCL2 mRNA]
CTD
PMID:27865854
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcl3
C-X-C motif chemokine ligand 3
multiple interactions
ISO
obeticholic acid inhibits the reaction [Carbon Tetrachloride results in increased expression of CXCL1 mRNA]
CTD
PMID:27865854
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
decreases expression
ISO
obeticholic acid results in decreased expression of CYP19A1 mRNA
CTD
PMID:27939613
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
decreases expression
ISO
obeticholic acid results in decreased expression of CYP1A1 mRNA
CTD
PMID:27939613
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions decreases expression decreases activity
ISO EXP
obeticholic acid inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of Acetaminophen]; obeticholic acid inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] obeticholic acid results in decreased expression of CYP1A2 mRNA obeticholic acid results in decreased activity of CYP1A2 protein [Dietary Fats co-treated with obeticholic acid] results in decreased expression of CYP1A2 mRNA; [Dietary Fats co-treated with obeticholic acid] results in decreased expression of CYP1A2 protein
CTD
PMID:27939613 PMID:35267068
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp27a1
cytochrome P450, family 27, subfamily a, polypeptide 1
decreases expression
ISO
obeticholic acid results in decreased expression of CYP27A1 mRNA
CTD
PMID:27939613
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
G
Cyp2c79
cytochrome P450, family 2, subfamily c, polypeptide 79
decreases expression
ISO
obeticholic acid results in decreased expression of CYP2C8 mRNA
CTD
PMID:27939613
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
increases expression
ISO
obeticholic acid results in increased expression of CYP2D6 mRNA
CTD
PMID:27939613
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases expression
ISO
obeticholic acid results in decreased expression of CYP2E1 mRNA
CTD
PMID:27939613
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp2r1
cytochrome P450, family 2, subfamily r, polypeptide 1
increases expression
ISO
obeticholic acid results in increased expression of CYP2R1 mRNA
CTD
PMID:27939613
NCBI chr 1:168,749,302...168,798,079
Ensembl chr 1:168,751,038...168,797,759
G
Cyp2s1
cytochrome P450, family 2, subfamily s, polypeptide 1
decreases expression
ISO
obeticholic acid results in decreased expression of CYP2S1 mRNA
CTD
PMID:27939613
NCBI chr 1:81,309,948...81,325,303
Ensembl chr 1:81,310,451...81,325,303
G
Cyp2u1
cytochrome P450, family 2, subfamily u, polypeptide 1
increases expression
ISO
obeticholic acid results in increased expression of CYP2U1 mRNA
CTD
PMID:27939613
NCBI chr 2:219,849,403...219,866,959
Ensembl chr 2:219,849,407...219,866,882
G
Cyp39a1
cytochrome P450, family 39, subfamily a, polypeptide 1
decreases expression
ISO
obeticholic acid results in decreased expression of CYP39A1 mRNA
CTD
PMID:27939613
NCBI chr 9:17,230,455...17,306,775
Ensembl chr 9:17,230,455...17,306,775
G
Cyp3a18
cytochrome P450, family 3, subfamily a, polypeptide 18
decreases expression
ISO
obeticholic acid results in decreased expression of CYP3A43 mRNA
CTD
PMID:27939613
NCBI chr12:8,880,509...8,930,382
Ensembl chr12:8,880,528...8,930,381
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions decreases activity decreases expression
ISO EXP
obeticholic acid inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 6 beta-hydroxytestosterone]; obeticholic acid inhibits the reaction [CYP3A4 protein results in increased metabolism of Testosterone] obeticholic acid results in decreased activity of CYP3A4 protein obeticholic acid results in decreased expression of CYP3A4 mRNA obeticholic acid results in decreased expression of CYP3A2 mRNA
CTD
PMID:27939613 PMID:35267068
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a23-3a1
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
decreases expression
EXP
obeticholic acid results in decreased expression of CYP3A23-3A1 mRNA
CTD
PMID:35267068
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
decreases expression
ISO
obeticholic acid results in decreased expression of CYP3A5 mRNA
CTD
PMID:27939613
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Cyp4f1
cytochrome P450, family 4, subfamily f, polypeptide 1
decreases expression
ISO
obeticholic acid results in decreased expression of CYP4F12 mRNA
CTD
PMID:27939613
NCBI chr 7:12,010,850...12,022,497
Ensembl chr 7:12,010,852...12,022,046
G
Cyp4f18
cytochrome P450, family 4, subfamily f, polypeptide 18
decreases expression
ISO
obeticholic acid results in decreased expression of CYP4F3 mRNA
CTD
PMID:27939613
NCBI chr16:17,763,543...17,804,944
Ensembl chr16:17,707,317...17,804,940
G
Cyp4f39
cytochrome P450, family 4, subfamily f, polypeptide 39
decreases expression
ISO
obeticholic acid results in decreased expression of CYP4F22 mRNA
CTD
PMID:27939613
NCBI chr 7:11,426,806...11,505,553
Ensembl chr 7:11,433,371...11,536,181
G
Cyp4f40
cytochrome P450, family 4, subfamily f, polypeptide 40
decreases expression
ISO
obeticholic acid results in decreased expression of CYP4F11 mRNA
CTD
PMID:27939613
NCBI chr 7:11,691,648...11,707,437
Ensembl chr 7:11,692,086...11,706,229
G
Cyp51
cytochrome P450, family 51
decreases expression
ISO
obeticholic acid results in decreased expression of CYP51A1 mRNA
CTD
PMID:27939613
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410 Ensembl chr 6:30,036,865...30,055,410
G
Cyp7a1
cytochrome P450 family 7 subfamily A member 1
decreases expression multiple interactions
ISO EXP
obeticholic acid results in decreased expression of CYP7A1 mRNA obeticholic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP7A1 protein]; obeticholic acid inhibits the reaction [[triptolide co-treated with Lipopolysaccharides] results in decreased expression of CYP7A1 protein]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA] obeticholic acid decreases expression of CYP7a1 mRNA in liver in porcine serum induced model of cirrhosis in rat Obeticholic acid inhibits the reaction [ethanol increases expression of Cyp7a1 protein in liver] obeticholic acid inhibits the reaction [Isoniazid results in increased expression of CYP7A1 mRNA]
CTD RGD
PMID:15644430 PMID:15911693 PMID:27939613 PMID:29660435 PMID:32673658 PMID:35267068 PMID:36328986 PMID:36787806 PMID:15521018 PMID:27939985 More...
RGD:15045602 , RGD:15036816
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
decreases expression increases expression multiple interactions
EXP ISO
obeticholic acid results in decreased expression of CYP8B1 mRNA obeticholic acid results in increased expression of CYP8B1 mRNA obeticholic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP8B1 mRNA]
CTD
PMID:15644430 PMID:27939613 PMID:29660435
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
G
Ddit3
DNA-damage inducible transcript 3
multiple interactions
ISO
obeticholic acid inhibits the reaction [Dietary Fats results in increased expression of DDIT3 protein]
CTD
PMID:26655953
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Dgat2
diacylglycerol O-acyltransferase 2
decreases expression
ISO
obeticholic acid results in decreased expression of DGAT2 mRNA
CTD
PMID:27939613
NCBI chr 1:153,454,078...153,484,432
Ensembl chr 1:153,454,080...153,484,428
G
Dhcr7
7-dehydrocholesterol reductase
increases expression
ISO
obeticholic acid results in increased expression of DHCR7 mRNA
CTD
PMID:27939613
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
G
Dnajb11
DnaJ heat shock protein family (Hsp40) member B11
increases expression
ISO
obeticholic acid results in increased expression of DNAJB11 mRNA
CTD
PMID:27939613
NCBI chr11:78,151,750...78,168,259
Ensembl chr11:78,150,429...78,180,407
G
Dpyd
dihydropyrimidine dehydrogenase
decreases expression
ISO
obeticholic acid results in decreased expression of DPYD mRNA
CTD
PMID:27939613
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
G
Dusp6
dual specificity phosphatase 6
increases expression
ISO
obeticholic acid results in increased expression of DUSP6 mRNA
CTD
PMID:27939613
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
G
Ecsit
ECSIT signaling integrator
decreases expression
ISO
obeticholic acid results in decreased expression of ECSIT mRNA
CTD
PMID:27939613
NCBI chr 8:20,605,583...20,618,453
Ensembl chr 8:20,605,583...20,618,390
G
Elovl1
ELOVL fatty acid elongase 1
increases expression
ISO
obeticholic acid results in increased expression of ELOVL1 mRNA
CTD
PMID:27939613
NCBI chr 5:131,961,478...131,965,961
Ensembl chr 5:131,961,322...131,965,958
G
Elovl2
ELOVL fatty acid elongase 2
increases expression
ISO
obeticholic acid results in increased expression of ELOVL2 mRNA
CTD
PMID:27939613
NCBI chr17:23,544,598...23,584,855
Ensembl chr17:23,544,568...23,584,848
G
Elovl6
ELOVL fatty acid elongase 6
decreases expression
ISO
obeticholic acid results in decreased expression of ELOVL6 mRNA
CTD
PMID:27939613
NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186
G
Elovl7
ELOVL fatty acid elongase 7
increases expression
ISO
obeticholic acid results in increased expression of ELOVL7 mRNA
CTD
PMID:27939613
NCBI chr 2:39,789,229...39,858,579
Ensembl chr 2:39,789,250...39,856,845
G
Enc1
ectodermal-neural cortex 1
increases expression
ISO
obeticholic acid results in increased expression of ENC1 mRNA
CTD
PMID:27939613
NCBI chr 2:28,550,670...28,562,591
Ensembl chr 2:28,550,464...28,562,713
G
Eno1
enolase 1
decreases expression
ISO
obeticholic acid results in decreased expression of ENO1 mRNA
CTD
PMID:27939613
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336 Ensembl chr 3:160,719,951...160,731,336
G
Eno3
enolase 3
increases expression
ISO
obeticholic acid results in increased expression of ENO3 mRNA
CTD
PMID:27939613
NCBI chr10:55,370,531...55,375,921
Ensembl chr10:55,366,975...55,375,921
G
Fabp6
fatty acid binding protein 6
multiple interactions increases expression
ISO
NR1H4 gene mutant form inhibits the reaction [obeticholic acid results in increased expression of FABP6 mRNA]
CTD
PMID:22918042
NCBI chr10:28,063,603...28,068,276
Ensembl chr10:28,063,603...28,068,282
G
Fadd
Fas associated via death domain
increases expression
ISO
obeticholic acid results in increased expression of FADD mRNA
CTD
PMID:27939613
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
G
Fas
Fas cell surface death receptor
multiple interactions
EXP
Obeticholic acid inhibits the reaction [ethanol increases expression of Fas mRNA and protein in liver]
RGD
PMID:27939985
RGD:15036816
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fasn
fatty acid synthase
multiple interactions decreases expression
ISO
obeticholic acid inhibits the reaction [Palmitic Acid results in increased expression of FASN mRNA] obeticholic acid results in decreased expression of FASN mRNA obeticholic acid inhibits the reaction [Ethanol results in increased expression of FASN protein]
CTD
PMID:26655953 PMID:27939613 PMID:27939985
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Fbp1
fructose-bisphosphatase 1
decreases expression
ISO
obeticholic acid results in decreased expression of FBP1 mRNA
CTD
PMID:27939613
NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,208,031...2,230,071
G
Fdps
farnesyl diphosphate synthase
decreases expression
ISO
obeticholic acid results in decreased expression of FDPS mRNA
CTD
PMID:27939613
NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
G
Fetub
fetuin B
increases expression
ISO
obeticholic acid results in increased expression of FETUB mRNA
CTD
PMID:27939613
NCBI chr11:78,082,158...78,093,022
Ensembl chr11:78,082,156...78,095,135
G
Fgf19
fibroblast growth factor 19
increases expression multiple interactions increases secretion
ISO EXP
obeticholic acid results in increased expression of FGF15 mRNA NR1H4 gene mutant form inhibits the reaction [obeticholic acid results in increased expression of FGF15 mRNA] obeticholic acid results in increased expression of FGF19 mRNA obeticholic acid results in increased secretion of FGF19 protein Obeticholic acid inhibits the reaction [ethanol decreases expression of FGF19 protein in liver and intestine]
CTD RGD
PMID:22918042 PMID:27939613 PMID:27939985
RGD:15036816
NCBI chr 1:200,056,526...200,060,980
Ensembl chr 1:200,056,644...200,060,287
G
Fgfr4
fibroblast growth factor receptor 4
decreases expression
ISO
obeticholic acid results in decreased expression of FGFR4 mRNA
CTD
PMID:27939613
NCBI chr17:9,461,541...9,476,268
Ensembl chr17:9,461,547...9,476,242
G
Fn1
fibronectin 1
decreases expression
EXP
obeticholic acid decreases expression of fibronectin mRNA in liver in porcine serum induced model of cirrhosis in rat
RGD
PMID:15980055
RGD:1625201
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
decreases expression
ISO
obeticholic acid results in decreased expression of FOS mRNA
CTD
PMID:27939613
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Foxm1
forkhead box M1
multiple interactions increases expression
ISO
NR1H4 affects the reaction [obeticholic acid results in increased expression of FOXM1 mRNA]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of FOXM1 protein]
CTD
PMID:22135065 PMID:29660435
NCBI chr 4:161,639,538...161,652,012
Ensembl chr 4:161,638,816...161,650,684
G
Foxp3
forkhead box P3
increases expression
ISO
obeticholic acid results in increased expression of FOXP3 mRNA
CTD
PMID:27939613
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
decreases expression
ISO
obeticholic acid results in decreased expression of GAPDH mRNA
CTD
PMID:27939613
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
G
Gclm
glutamate cysteine ligase, modifier subunit
increases expression
ISO
obeticholic acid results in increased expression of GCLM mRNA
CTD
PMID:26655953
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Gfer
growth factor, augmenter of liver regeneration
multiple interactions
ISO
[Dietary Fats co-treated with obeticholic acid] results in decreased expression of GFER mRNA; [Dietary Fats co-treated with obeticholic acid] results in decreased expression of GFER protein
CTD
PMID:35267068
NCBI chr10:13,718,489...13,721,782
Ensembl chr10:13,718,489...13,720,869
G
Gk
glycerol kinase
decreases expression
ISO
obeticholic acid results in decreased expression of GK mRNA
CTD
PMID:27939613
NCBI chr X:50,162,089...50,238,707
Ensembl chr X:50,163,123...50,238,631
G
Gpam
glycerol-3-phosphate acyltransferase, mitochondrial
decreases expression
ISO
obeticholic acid results in decreased expression of GPAM mRNA
CTD
PMID:27939613
NCBI chr 1:254,106,323...254,170,755
Ensembl chr 1:254,106,331...254,142,639
G
Gpd1
glycerol-3-phosphate dehydrogenase 1
decreases expression
ISO
obeticholic acid results in decreased expression of GPD1 mRNA
CTD
PMID:27939613
NCBI chr 7:130,842,526...130,851,530
Ensembl chr 7:130,844,138...130,851,529
G
Gpt
glutamic--pyruvic transaminase
multiple interactions
ISO
obeticholic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of GPT protein]; obeticholic acid inhibits the reaction [[triptolide co-treated with Lipopolysaccharides] results in increased expression of GPT protein]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased activity of GPT protein]; obeticholic acid promotes the reaction [Dietary Fats results in increased expression of GPT protein]
CTD
PMID:35267068 PMID:36328986 PMID:36581201 PMID:36787806
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Gpx1
glutathione peroxidase 1
increases expression
ISO
obeticholic acid results in increased expression of GPX1 mRNA
CTD
PMID:26655953
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gpx2
glutathione peroxidase 2
decreases expression
ISO
obeticholic acid results in decreased expression of GPX2 mRNA
CTD
PMID:27939613
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
G
Gpx3
glutathione peroxidase 3
increases expression
ISO
obeticholic acid results in increased expression of GPX3 mRNA
CTD
PMID:27939613
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
G
Gsdmd
gasdermin D
multiple interactions
ISO
obeticholic acid inhibits the reaction [[triptolide co-treated with Lipopolysaccharides] results in increased cleavage of GSDMD protein]
CTD
PMID:36328986
NCBI chr 7:107,542,489...107,547,051
Ensembl chr 7:107,542,083...107,547,055
G
Gsr
glutathione-disulfide reductase
increases expression
ISO
obeticholic acid results in increased expression of GSR mRNA
CTD
PMID:26655953 PMID:27939613
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Gstp1
glutathione S-transferase pi 1
decreases expression
ISO
obeticholic acid results in decreased expression of GSTP1 mRNA
CTD
PMID:27939613
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Gstt1
glutathione S-transferase theta 1
increases expression
ISO
obeticholic acid results in increased expression of GSTT1 mRNA
CTD
PMID:27939613
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
G
Gys2
glycogen synthase 2
increases expression
ISO
obeticholic acid results in increased expression of GYS2 mRNA
CTD
PMID:27939613
NCBI chr 4:175,365,054...175,406,228
Ensembl chr 4:175,365,054...175,406,228
G
Hist2h2be
histone cluster 2 H2B family member E
decreases expression
ISO
obeticholic acid results in decreased expression of H2BC11 mRNA
CTD
PMID:27939613
NCBI chr 2:183,780,583...183,783,030
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
decreases expression
ISO
obeticholic acid results in decreased expression of HMGCR mRNA
CTD
PMID:27939613
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
G
Hmgcs1
3-hydroxy-3-methylglutaryl-CoA synthase 1
decreases expression
ISO
obeticholic acid results in decreased expression of HMGCS1 mRNA
CTD
PMID:27939613
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
G
Hnf4a
hepatocyte nuclear factor 4, alpha
decreases expression multiple interactions
EXP ISO
obeticholic acid results in decreased expression of HNF4A mRNA [Dietary Fats co-treated with obeticholic acid] results in decreased expression of HNF4A mRNA; [Dietary Fats co-treated with obeticholic acid] results in decreased expression of HNF4A protein
CTD
PMID:35267068
NCBI chr 3:152,186,787...152,248,320
Ensembl chr 3:152,186,787...152,248,320
G
Hras
HRas proto-oncogene, GTPase
decreases expression
ISO
obeticholic acid results in decreased expression of HRAS mRNA
CTD
PMID:27939613
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
G
Hsd17b7
hydroxysteroid (17-beta) dehydrogenase 7
decreases expression
ISO
obeticholic acid results in decreased expression of HSD17B7 mRNA
CTD
PMID:27939613
NCBI chr13:82,170,079...82,190,018
Ensembl chr13:82,173,179...82,190,017
G
Hsd3b7
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7
decreases expression
ISO
obeticholic acid results in decreased expression of HSD3B7 mRNA
CTD
PMID:27939613
NCBI chr 1:182,412,216...182,415,447
Ensembl chr 1:182,412,151...182,415,442
G
Hspa5
heat shock protein family A (Hsp70) member 5
multiple interactions
ISO
obeticholic acid inhibits the reaction [Dietary Fats results in increased expression of HSPA5 protein]; obeticholic acid inhibits the reaction [Palmitic Acid results in increased expression of HSPA5 protein]
CTD
PMID:26655953
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Hspg2
heparan sulfate proteoglycan 2
decreases expression
ISO
obeticholic acid results in decreased expression of HSPG2 mRNA
CTD
PMID:27939613
NCBI chr 5:149,677,437...149,778,594
Ensembl chr 5:149,677,476...149,778,594
G
Id2
inhibitor of DNA binding 2
decreases expression
ISO
obeticholic acid results in decreased expression of ID2 mRNA
CTD
PMID:27939613
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
G
Idi1
isopentenyl-diphosphate delta isomerase 1
decreases expression
ISO
obeticholic acid results in decreased expression of IDI1 mRNA
CTD
PMID:27939613
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
G
Igfals
insulin-like growth factor binding protein, acid labile subunit
decreases expression
ISO
obeticholic acid results in decreased expression of IGFALS mRNA
CTD
PMID:27939613
NCBI chr10:13,897,468...13,903,920
Ensembl chr10:13,898,395...13,902,677
G
Il10
interleukin 10
multiple interactions
ISO
obeticholic acid inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of IL10 protein]; obeticholic acid inhibits the reaction [Dietary Fats results in increased expression of IL10 protein]
CTD
PMID:30745416
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il18
interleukin 18
multiple interactions
ISO
obeticholic acid inhibits the reaction [Methamphetamine results in increased expression of IL18 mRNA]
CTD
PMID:35688268
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1b
interleukin 1 beta
multiple interactions
ISO
obeticholic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL1B mRNA]; obeticholic acid inhibits the reaction [Carbon Tetrachloride results in increased expression of IL1B mRNA]; obeticholic acid inhibits the reaction [Dietary Fats results in increased expression of IL1B protein]; obeticholic acid inhibits the reaction [Methamphetamine results in increased expression of IL1B mRNA]
CTD
PMID:27865854 PMID:29660435 PMID:35688268 PMID:38103844
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il4
interleukin 4
multiple interactions
ISO
obeticholic acid promotes the reaction [Carbon Tetrachloride results in increased expression of IL4 mRNA]
CTD
PMID:27865854
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il6
interleukin 6
multiple interactions
ISO
obeticholic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL6 mRNA]; obeticholic acid inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of IL6 protein]; obeticholic acid inhibits the reaction [Dietary Fats results in increased expression of IL6 protein]; obeticholic acid inhibits the reaction [Methamphetamine results in increased expression of IL6 mRNA]
CTD
PMID:29660435 PMID:30745416 PMID:35688268 PMID:36720452 PMID:38103844
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il6r
interleukin 6 receptor
decreases expression
ISO
obeticholic acid results in decreased expression of IL6R mRNA
CTD
PMID:27939613
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
G
Il6st
interleukin 6 cytokine family signal transducer
decreases expression
ISO
obeticholic acid results in decreased expression of IL6ST mRNA
CTD
PMID:27939613
NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
G
Inhbb
inhibin subunit beta B
increases expression
ISO
obeticholic acid results in increased expression of INHBB mRNA
CTD
PMID:27939613
NCBI chr13:30,530,860...30,536,566
Ensembl chr13:30,530,860...30,537,832
G
Irak1
interleukin-1 receptor-associated kinase 1
decreases expression
ISO
obeticholic acid results in decreased expression of IRAK1 mRNA
CTD
PMID:27939613
NCBI chr X:151,768,621...151,778,521
Ensembl chr X:151,768,777...151,778,521
G
Irak2
interleukin-1 receptor-associated kinase 2
decreases expression
ISO
obeticholic acid results in decreased expression of IRAK2 mRNA
CTD
PMID:27939613
NCBI chr 4:146,786,004...146,842,615
Ensembl chr 4:146,786,100...146,842,602
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
obeticholic acid results in increased expression of JUN mRNA
CTD
PMID:27939613
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
decreases expression
ISO
obeticholic acid results in decreased expression of JUNB mRNA
CTD
PMID:27939613
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
G
Jund
JunD proto-oncogene, AP-1 transcription factor subunit
multiple interactions
EXP
NR0B2 protein affects the reaction [obeticholic acid inhibits the reaction [JUND protein binds to TIMP1 promoter]]
CTD
PMID:15860571
NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
G
Krt18
keratin 18
multiple interactions
ISO
[Dietary Fats co-treated with obeticholic acid] results in decreased expression of KRT18 mRNA
CTD
PMID:35267068
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166 Ensembl chr10:133,157,475...133,161,166
G
Lbr
lamin B receptor
decreases expression
ISO
obeticholic acid results in decreased expression of LBR mRNA
CTD
PMID:27939613
NCBI chr13:93,539,386...93,564,026
Ensembl chr13:93,538,920...93,564,017
G
Lcat
lecithin cholesterol acyltransferase
decreases expression
ISO
obeticholic acid results in decreased expression of LCAT mRNA
CTD
PMID:27939613
NCBI chr19:33,834,748...33,838,214
Ensembl chr19:33,834,403...33,838,231
G
Ldlr
low density lipoprotein receptor
decreases expression
ISO
obeticholic acid results in decreased expression of LDLR mRNA
CTD
PMID:27939613
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
G
Leng8
leukocyte receptor cluster member 8
increases expression
ISO
obeticholic acid results in increased expression of LENG8 mRNA
CTD
PMID:27939613
NCBI chr 1:70,040,785...70,052,662
Ensembl chr 1:70,040,785...70,052,488
G
Lgi4
leucine-rich repeat LGI family, member 4
increases expression
ISO
obeticholic acid results in increased expression of LGI4 mRNA
CTD
PMID:27939613
NCBI chr 1:86,294,539...86,305,909
Ensembl chr 1:86,295,074...86,304,874
G
Lime1
Lck interacting transmembrane adaptor 1
decreases expression
ISO
obeticholic acid results in decreased expression of LIME1 mRNA
CTD
PMID:27939613
NCBI chr 3:168,490,535...168,496,627
Ensembl chr 3:168,490,074...168,493,127
G
Lipc
lipase C, hepatic type
decreases expression
ISO
obeticholic acid results in decreased expression of LIPC mRNA
CTD
PMID:27939613
NCBI chr 8:71,509,633...71,635,663
Ensembl chr 8:71,509,635...71,635,464
G
Lpin1
lipin 1
decreases expression
ISO
obeticholic acid results in decreased expression of LPIN1 mRNA
CTD
PMID:27939613
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
G
Lpin2
lipin 2
decreases expression
ISO
obeticholic acid results in decreased expression of LPIN2 mRNA
CTD
PMID:27939613
NCBI chr 9:111,083,378...111,158,193
Ensembl chr 9:111,083,745...111,158,193
G
Lss
lanosterol synthase
decreases expression
ISO
obeticholic acid results in decreased expression of LSS mRNA
CTD
PMID:27939613
NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,092,774...12,118,762
G
Maf
MAF bZIP transcription factor
increases expression
ISO
obeticholic acid results in increased expression of MAF mRNA
CTD
PMID:27939613
NCBI chr19:43,353,867...43,713,162
Ensembl chr19:43,360,342...43,712,365
G
Maff
MAF bZIP transcription factor F
increases expression
ISO
obeticholic acid results in increased expression of MAFF mRNA
CTD
PMID:27939613
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
multiple interactions
ISO
obeticholic acid inhibits the reaction [Dietary Fats results in decreased expression of MAP1LC3B protein]
CTD
PMID:26655953
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690 Ensembl chr16:49,665,791...49,677,690
G
Map2k3
mitogen activated protein kinase kinase 3
decreases expression
ISO
obeticholic acid results in decreased expression of MAP2K3 mRNA
CTD
PMID:27939613
NCBI chr10:45,608,145...45,629,492
Ensembl chr10:45,607,163...45,629,492
G
Map2k6
mitogen-activated protein kinase kinase 6
decreases expression
ISO
obeticholic acid results in decreased expression of MAP2K6 mRNA
CTD
PMID:27939613
NCBI chr10:95,373,304...95,490,406
Ensembl chr10:95,373,204...95,488,293
G
Map2k7
mitogen activated protein kinase kinase 7
decreases expression
ISO
obeticholic acid results in decreased expression of MAP2K7 mRNA
CTD
PMID:27939613
NCBI chr12:2,591,312...2,600,534
Ensembl chr12:2,591,219...2,604,222
G
Map3k14
mitogen-activated protein kinase kinase kinase 14
decreases expression
ISO
obeticholic acid results in decreased expression of MAP3K14 mRNA
CTD
PMID:27939613
NCBI chr10:88,165,349...88,215,558
Ensembl chr10:88,165,351...88,215,523
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
decreases expression
ISO
obeticholic acid results in decreased expression of MAP3K5 mRNA
CTD
PMID:27939613
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
G
Map3k8
mitogen-activated protein kinase kinase kinase 8
increases expression
ISO
obeticholic acid results in increased expression of MAP3K8 mRNA
CTD
PMID:27939613
NCBI chr17:53,382,908...53,403,216
Ensembl chr17:53,383,131...53,403,216
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
obeticholic acid inhibits the reaction [Carbon Tetrachloride results in increased phosphorylation of MAPK1 protein]
CTD
PMID:27865854
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk11
mitogen-activated protein kinase 11
decreases expression
ISO
obeticholic acid results in decreased expression of MAPK11 mRNA
CTD
PMID:27939613
NCBI chr 7:120,218,471...120,225,488
Ensembl chr 7:120,218,478...120,225,395
G
Mapk12
mitogen-activated protein kinase 12
decreases expression
ISO
obeticholic acid results in decreased expression of MAPK12 mRNA
CTD
PMID:27939613
NCBI chr 7:120,206,005...120,216,711
Ensembl chr 7:120,206,271...120,216,664
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
obeticholic acid inhibits the reaction [Carbon Tetrachloride results in increased phosphorylation of MAPK3 protein]
CTD
PMID:27865854
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mdh1
malate dehydrogenase 1
increases expression
ISO
obeticholic acid results in increased expression of MDH1 mRNA
CTD
PMID:27939613
NCBI chr14:95,630,625...95,645,920
Ensembl chr14:95,630,306...95,645,925
G
Metrnl
meteorin-like, glial cell differentiation regulator
decreases expression
ISO
obeticholic acid results in decreased expression of METRNL mRNA
CTD
PMID:27939613
NCBI chr10:106,963,880...106,977,875
Ensembl chr10:106,963,880...106,977,869
G
Mfsd2a
MFSD2 lysolipid transporter A, lysophospholipid
increases expression
ISO
obeticholic acid results in increased expression of MFSD2A mRNA
CTD
PMID:27939613
NCBI chr 5:135,225,801...135,240,744
Ensembl chr 5:135,225,816...135,240,690
G
Mlkl
mixed lineage kinase domain like pseudokinase
decreases expression
ISO
obeticholic acid results in decreased expression of MLKL mRNA
CTD
PMID:27939613
NCBI chr19:39,277,526...39,304,555
Ensembl chr19:39,276,785...39,304,502
G
Mllt11
MLLT11, transcription factor 7 cofactor
increases expression
ISO
obeticholic acid results in increased expression of MLLT11 mRNA
CTD
PMID:27939613
NCBI chr 2:182,795,790...182,804,960
Ensembl chr 2:182,795,790...182,797,199
G
Mmp2
matrix metallopeptidase 2
increases activity
EXP
obeticholic acid results in increased activity of MMP2 protein
CTD
PMID:15860571
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mpo
myeloperoxidase
multiple interactions
ISO
obeticholic acid inhibits the reaction [[triptolide co-treated with Lipopolysaccharides] results in increased expression of MPO protein]
CTD
PMID:36328986
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Mrtfb
myocardin related transcription factor B
decreases expression
ISO
obeticholic acid results in decreased expression of MRTFB mRNA
CTD
PMID:27939613
NCBI chr10:1,116,315...1,278,106
Ensembl chr10:1,116,310...1,277,897
G
Msmo1
methylsterol monooxygenase 1
decreases expression
ISO
obeticholic acid results in decreased expression of MSMO1 mRNA
CTD
PMID:27939613
NCBI chr16:24,980,680...24,997,927
Ensembl chr16:24,980,697...24,998,016
G
Mvd
mevalonate diphosphate decarboxylase
decreases expression
ISO
obeticholic acid results in decreased expression of MVD mRNA
CTD
PMID:27939613
NCBI chr19:50,496,366...50,506,429
Ensembl chr19:50,496,367...50,507,971
G
Mvk
mevalonate kinase
decreases expression
ISO
obeticholic acid results in decreased expression of MVK mRNA
CTD
PMID:27939613
NCBI chr12:42,141,391...42,158,893
Ensembl chr12:42,141,384...42,158,882
G
Myc
MYC proto-oncogene, bHLH transcription factor
decreases expression
ISO
obeticholic acid results in decreased expression of MYC mRNA
CTD
PMID:27939613
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Myd88
MYD88, innate immune signal transduction adaptor
multiple interactions
ISO
obeticholic acid inhibits the reaction [Methamphetamine results in increased expression of MYD88 protein]
CTD
PMID:35688268 PMID:36720452
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
G
Nfe2l2
NFE2 like bZIP transcription factor 2
increases expression multiple interactions
ISO
obeticholic acid results in increased expression of NFE2L2 mRNA [Dietary Fats co-treated with obeticholic acid] results in decreased expression of NFE2L2 protein
CTD
PMID:27939613 PMID:35267068
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfkb1
nuclear factor kappa B subunit 1
increases expression multiple interactions
ISO EXP
obeticholic acid results in increased expression of NFKB1 mRNA Obeticholic acid inhibits the reaction [ethanol increases expression of NF-kB protein in liver]
CTD RGD
PMID:27939613 PMID:27939985
RGD:15036816
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nfkb2
nuclear factor kappa B subunit 2
decreases expression
ISO
obeticholic acid results in decreased expression of NFKB2 mRNA
CTD
PMID:27939613
NCBI chr 1:245,164,586...245,173,225
Ensembl chr 1:245,165,950...245,173,213
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
EXP
Obeticholic acid inhibits the reaction [ethanol decreases expression of Nfkbia protein in liver]
RGD
PMID:27939985
RGD:15036816
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nlrp3
NLR family, pyrin domain containing 3
multiple interactions
EXP
Obeticholic acid inhibits the reaction [ethanol increases expression of Nrlp3 protein in liver]
RGD
PMID:27939985
RGD:15036816
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
G
Npw
neuropeptide W
decreases expression
ISO
obeticholic acid results in decreased expression of NPW mRNA
CTD
PMID:27939613
NCBI chr10:13,680,275...13,681,618
Ensembl chr10:13,680,321...13,681,586
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
multiple interactions increases expression
ISO EXP
obeticholic acid promotes the reaction [PRMT2 protein binds to NR0B2 promoter] obeticholic acid results in increased expression of NR0B2 mRNA obeticholic acid results in increased expression of NR0B2 mRNA; obeticholic acid results in increased expression of NR0B2 protein NR0B2 protein affects the reaction [obeticholic acid inhibits the reaction [JUND protein binds to TIMP1 promoter]]; NR0B2 protein affects the reaction [obeticholic acid results in decreased expression of and results in decreased secretion of TIMP1 protein]; obeticholic acid inhibits the reaction [Isoniazid results in decreased expression of NR0B2 mRNA]; obeticholic acid inhibits the reaction [Pyrazinamide results in decreased expression of NR0B2 mRNA] Obeticholic acid inhibits the reaction [ethanol decreases expression of Nr0b2 protein in liver and intestine] obeticholic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR0B2 protein]; obeticholic acid inhibits the reaction [[triptolide co-treated with Lipopolysaccharides] results in decreased expression of NR0B2 protein]; obeticholic acid inhibits the reaction [Dietary Fats results in decreased expression of NR0B2 mRNA]
CTD RGD
PMID:15644430 PMID:15860571 PMID:15911693 PMID:15980055 PMID:26655953 PMID:27255380 PMID:27939613 PMID:32673658 PMID:35267068 PMID:36328986 PMID:36787806 PMID:27939985 More...
RGD:15036816
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
increases activity multiple interactions increases response to substance increases expression
ISO EXP
obeticholic acid results in increased activity of NR1H4 protein obeticholic acid binds to and results in increased activity of NR1H4 protein; obeticholic acid promotes the reaction [NR1H4 protein binds to PRMT1 protein] [obeticholic acid co-treated with 1-Naphthylisothiocyanate] results in increased expression of NR1H4 protein; NR1H4 affects the reaction [obeticholic acid results in increased expression of FOXM1 mRNA]; NR1H4 gene mutant form inhibits the reaction [obeticholic acid inhibits the reaction [TNF results in increased expression of SELP mRNA]]; NR1H4 gene mutant form inhibits the reaction [obeticholic acid results in increased expression of FABP6 mRNA]; NR1H4 gene mutant form inhibits the reaction [obeticholic acid results in increased expression of FGF15 mRNA]; NR1H4 promotes the reaction [obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC2 mRNA]]; obeticholic acid binds to and results in increased activity of NR1H4 protein; obeticholic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NR1H4 mRNA]; obeticholic acid inhibits the reaction [[triptolide co-treated with Lipopolysaccharides] results in decreased expression of NR1H4 protein]; obeticholic acid inhibits the reaction [Methamphetamine results in increased expression of NR1H4 mRNA]; obeticholic acid inhibits the reaction [Methamphetamine results in increased expression of NR1H4 protein] NR1H4 protein results in increased susceptibility to obeticholic acid obeticholic acid binds to and results in increased activity of NR1H4 protein; obeticholic acid inhibits the reaction [Isoniazid results in decreased expression of NR1H4 mRNA]; obeticholic acid inhibits the reaction [Pyrazinamide results in decreased expression of NR1H4 mRNA] obeticholic acid results in increased expression of NR1H4 mRNA obeticholic acid results in increased expression of NR1H4 protein obeticholic acid increases expression of Nr1H4 mRNA in rat hepatic stellate cells; obeticholic acid increases expression of Nr1h4 mRNA in bile duct ligation and porcine serum induced models of cirrhosis in rat Obeticholic acid inhibits the reaction [ethanol decreases expression of Nr1h4 mRNA and protein in liver and liver cell nuclei and intestine]
CTD RGD
PMID:15860571 PMID:15911693 PMID:15980055 PMID:17567710 PMID:21242261 PMID:22135065 PMID:22918042 PMID:27255380 PMID:27865854 PMID:27871908 PMID:28887089 PMID:29660435 PMID:32673658 PMID:35688268 PMID:36328986 PMID:36787806 PMID:15980055 PMID:27939985 More...
RGD:1625201 , RGD:15036816
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
G
Nr5a2
nuclear receptor subfamily 5, group A, member 2
decreases expression
ISO
obeticholic acid results in decreased expression of NR5A2 mRNA
CTD
PMID:27939613
NCBI chr13:48,313,634...48,433,494
Ensembl chr13:48,316,301...48,433,326
G
Ocln
occludin
multiple interactions
ISO
obeticholic acid inhibits the reaction [Methamphetamine results in decreased expression of OCLN protein]; obeticholic acid promotes the reaction [[Dietary Fats co-treated with Dextran Sulfate] results in increased expression of OCLN protein]
CTD
PMID:35439472 PMID:36720452
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
G
P4hb
prolyl 4-hydroxylase subunit beta
increases expression
ISO
obeticholic acid results in increased expression of P4HB mRNA
CTD
PMID:27939613
NCBI chr10:105,836,972...105,848,583
Ensembl chr10:105,836,982...105,848,500
G
Pc
pyruvate carboxylase
decreases expression
ISO
obeticholic acid results in decreased expression of PC mRNA
CTD
PMID:27939613
NCBI chr 1:201,799,374...201,898,412
Ensembl chr 1:201,804,267...201,898,380
G
Pck1
phosphoenolpyruvate carboxykinase 1
decreases expression
ISO
obeticholic acid results in decreased expression of PCK1 mRNA
CTD
PMID:27939613
NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
G
Pfkfb1
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1
increases expression
ISO
obeticholic acid results in increased expression of PFKFB1 mRNA
CTD
PMID:27939613
NCBI chr X:19,508,522...19,562,165
Ensembl chr X:19,508,546...19,562,182
G
Pgm1
phosphoglucomutase 1
decreases expression
ISO
obeticholic acid results in decreased expression of PGM1 mRNA
CTD
PMID:27939613
NCBI chr 5:114,595,298...114,654,728
Ensembl chr 5:114,595,293...114,654,728
G
Pik3cd
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
decreases expression
ISO
obeticholic acid results in decreased expression of PIK3CD mRNA
CTD
PMID:27939613
NCBI chr 5:160,094,952...160,142,962
Ensembl chr 5:160,094,952...160,120,930
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
decreases expression
ISO
obeticholic acid results in decreased expression of PIK3R1 mRNA
CTD
PMID:27939613
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
G
Pltp
phospholipid transfer protein
decreases expression
ISO
obeticholic acid results in decreased expression of PLTP mRNA
CTD
PMID:27939613
NCBI chr 3:153,574,825...153,592,647
Ensembl chr 3:153,574,825...153,592,647
G
Ppara
peroxisome proliferator activated receptor alpha
multiple interactions increases expression
ISO EXP
Palmitic Acid inhibits the reaction [obeticholic acid results in increased expression of PPARA mRNA] obeticholic acid results in increased expression of PPARA mRNA; obeticholic acid results in increased expression of PPARA protein obeticholic acid inhibits the reaction [Ethanol results in decreased expression of PPARA protein] Obeticholic acid inhibits the reaction [ethanol decreases expression of Ppara mRNA and protein in liver]
CTD RGD
PMID:15980055 PMID:26655953 PMID:27939985 PMID:27939985
RGD:15036816
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Pparg
peroxisome proliferator-activated receptor gamma
increases expression
EXP
obeticholic acid results in increased expression of PPARG mRNA; obeticholic acid results in increased expression of PPARG protein
CTD
PMID:15980055
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppp1r3c
protein phosphatase 1, regulatory subunit 3C
decreases expression
ISO
obeticholic acid results in decreased expression of PPP1R3C mRNA
CTD
PMID:27939613
NCBI chr 1:234,460,958...234,465,961
Ensembl chr 1:234,460,652...234,465,961
G
Ppp2cb
protein phosphatase 2 catalytic subunit beta
increases expression
ISO
obeticholic acid results in increased expression of PPP2CB mRNA
CTD
PMID:27939613
NCBI chr16:58,558,119...58,579,325
Ensembl chr16:58,558,122...58,579,576
G
Ppp2r1b
protein phosphatase 2 scaffold subunit A beta
increases expression
ISO
obeticholic acid results in increased expression of PPP2R1B mRNA
CTD
PMID:27939613
NCBI chr 8:51,195,860...51,228,442
Ensembl chr 8:51,186,717...51,228,485
G
Prdx1
peroxiredoxin 1
decreases expression
ISO
obeticholic acid results in decreased expression of PRDX1 mRNA
CTD
PMID:27939613
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
G
Prdx6
peroxiredoxin 6
decreases expression
ISO
obeticholic acid results in decreased expression of PRDX6 mRNA
CTD
PMID:27939613
NCBI chr13:73,528,746...73,539,295
Ensembl chr13:73,528,210...73,539,355
G
Prkca
protein kinase C, alpha
increases expression
ISO
obeticholic acid results in increased expression of PRKCA mRNA
CTD
PMID:27939613
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
G
Prkce
protein kinase C, epsilon
increases expression
ISO
obeticholic acid results in increased expression of PRKCE mRNA
CTD
PMID:27939613
NCBI chr 6:7,965,048...8,451,966
Ensembl chr 6:7,965,048...8,451,719
G
Prmt1
protein arginine methyltransferase 1
multiple interactions increases activity
ISO
obeticholic acid promotes the reaction [NR1H4 protein binds to PRMT1 protein]; obeticholic acid promotes the reaction [PRMT1 protein binds to ABCB11 promoter] obeticholic acid results in increased activity of PRMT1 protein
CTD
PMID:15911693
NCBI chr 1:95,458,853...95,468,176
Ensembl chr 1:95,458,850...95,468,345
G
Prmt2
protein arginine methyltransferase 2
multiple interactions
ISO
obeticholic acid promotes the reaction [PRMT2 protein binds to NR0B2 promoter]
CTD
PMID:15911693
NCBI chr20:12,394,748...12,420,643
Ensembl chr20:12,394,798...12,420,643
G
Ptbp2
polypyrimidine tract binding protein 2
decreases expression
ISO
obeticholic acid results in decreased expression of PTBP2 mRNA
CTD
PMID:27939613
NCBI chr 2:207,812,659...207,874,019
Ensembl chr 2:207,812,920...207,873,506
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
obeticholic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of RELA protein]; obeticholic acid inhibits the reaction [Methamphetamine results in increased expression of and results in increased phosphorylation of RELA protein]; obeticholic acid inhibits the reaction [Methamphetamine results in increased expression of RELA protein]
CTD
PMID:29660435 PMID:35688268 PMID:36720452
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Ros1
ROS proto-oncogene 1 , receptor tyrosine kinase
increases expression
ISO
obeticholic acid results in increased expression of ROS1 mRNA
CTD
PMID:27939613
NCBI chr20:31,432,636...31,583,998
Ensembl chr20:31,432,637...31,583,865
G
Rps6ka2
ribosomal protein S6 kinase A2
increases expression
ISO
obeticholic acid results in increased expression of RPS6KA2 mRNA
CTD
PMID:27939613
NCBI chr 1:52,631,582...52,906,739
Ensembl chr 1:52,631,736...52,906,739
G
Rps6ka4
ribosomal protein S6 kinase A4
decreases expression
ISO
obeticholic acid results in decreased expression of RPS6KA4 mRNA
CTD
PMID:27939613
NCBI chr 1:204,021,805...204,032,781
Ensembl chr 1:204,021,806...204,032,761
G
Rps6ka5
ribosomal protein S6 kinase A5
decreases expression
ISO
obeticholic acid results in decreased expression of RPS6KA5 mRNA
CTD
PMID:27939613
NCBI chr 6:119,828,823...120,006,190
Ensembl chr 6:119,828,846...120,006,224
G
Rras2
RAS related 2
increases expression
ISO
obeticholic acid results in increased expression of RRAS2 mRNA
CTD
PMID:27939613
NCBI chr 1:168,233,693...168,303,111
Ensembl chr 1:168,233,693...168,303,111
G
Rtp3
receptor (chemosensory) transporter protein 3
increases expression
ISO
obeticholic acid results in increased expression of RTP3 mRNA
CTD
PMID:27939613
NCBI chr 8:110,970,154...110,975,000
Ensembl chr 8:110,970,160...110,974,699
G
Rxra
retinoid X receptor alpha
decreases expression
ISO
obeticholic acid results in decreased expression of RXRA mRNA
CTD
PMID:27939613
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
G
S100a3
S100 calcium binding protein A3
decreases expression
ISO
obeticholic acid results in decreased expression of S100A3 mRNA
CTD
PMID:27939613
NCBI chr 2:176,034,283...176,089,702
Ensembl chr 2:176,049,520...176,089,702
G
Sc5d
sterol-C5-desaturase
decreases expression
ISO
obeticholic acid results in decreased expression of SC5D mRNA
CTD
PMID:27939613
NCBI chr 8:42,629,649...42,641,257
Ensembl chr 8:42,632,672...42,641,273
G
Scarb1
scavenger receptor class B, member 1
increases expression
ISO
obeticholic acid results in increased expression of SCARB1 mRNA
CTD
PMID:27939613
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
G
Sdc1
syndecan 1
increases expression
ISO
obeticholic acid results in increased expression of SDC1 mRNA
CTD
PMID:27939613
NCBI chr 6:31,562,799...31,585,267
Ensembl chr 6:31,562,739...31,585,264
G
Sdha
succinate dehydrogenase complex flavoprotein subunit A
multiple interactions
ISO
obeticholic acid inhibits the reaction [Dietary Fats results in decreased expression of SDHA protein]
CTD
PMID:26655953
NCBI chr 1:28,935,965...28,960,936
Ensembl chr 1:28,940,164...28,961,535
G
Selp
selectin P
multiple interactions
ISO
NR1H4 gene mutant form inhibits the reaction [obeticholic acid inhibits the reaction [TNF results in increased expression of SELP mRNA]]; obeticholic acid inhibits the reaction [TNF results in increased expression of SELP mRNA]
CTD
PMID:22135065
NCBI chr13:76,476,229...76,511,846
Ensembl chr13:76,476,295...76,511,845
G
Serpina1
serpin family A member 1
decreases expression
ISO
obeticholic acid results in decreased expression of SERPINA1 mRNA
CTD
PMID:27939613
NCBI chr 6:122,866,314...122,888,339
Ensembl chr 6:122,866,312...122,888,339
G
Serpine1
serpin family E member 1
decreases expression
ISO
obeticholic acid results in decreased expression of SERPINE1 mRNA
CTD
PMID:27939613
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Sfn
stratifin
decreases expression
ISO
obeticholic acid results in decreased expression of SFN mRNA
CTD
PMID:27939613
NCBI chr 5:145,826,722...145,827,994
Ensembl chr 5:145,826,201...145,831,314
G
Sigirr
single Ig and TIR domain containing
decreases expression
ISO
obeticholic acid results in decreased expression of SIGIRR mRNA
CTD
PMID:27939613
NCBI chr 1:196,195,363...196,208,692
Ensembl chr 1:196,199,462...196,202,269
G
Slc10a1
solute carrier family 10 member 1
decreases expression multiple interactions
ISO EXP
obeticholic acid results in decreased expression of SLC10A1 mRNA [1-Naphthylisothiocyanate co-treated with obeticholic acid] results in decreased expression of SLC10A1 protein; obeticholic acid inhibits the reaction [[triptolide co-treated with Lipopolysaccharides] results in decreased expression of SLC10A1 mRNA]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 mRNA]; obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 protein] Obeticholic acid inhibits the reaction [ethanol decreases expression of Slc10a1 protein in liver] obeticholic acid promotes the reaction [Isoniazid results in decreased expression of SLC10A1 mRNA]
CTD RGD
PMID:15644430 PMID:15911693 PMID:29660435 PMID:32673658 PMID:36328986 PMID:36787806 PMID:27939985 More...
RGD:15036816
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
G
Slc13a5
solute carrier family 13 member 5
decreases expression
ISO
obeticholic acid results in decreased expression of SLC13A5 mRNA
CTD
PMID:27939613
NCBI chr10:56,866,249...56,891,189
Ensembl chr10:56,866,249...56,890,945
G
Slc25a1
solute carrier family 25 member 1
decreases expression
ISO
obeticholic acid results in decreased expression of SLC25A1 mRNA
CTD
PMID:27939613
NCBI chr11:83,055,764...83,058,781
Ensembl chr11:83,055,748...83,058,781
G
Slc25a10
solute carrier family 25 member 10
decreases expression
ISO
obeticholic acid results in decreased expression of SLC25A10 mRNA
CTD
PMID:27939613
NCBI chr10:105,765,598...105,775,159
Ensembl chr10:105,765,372...105,773,556
G
Slc25a12
solute carrier family 25 member 12
decreases expression
ISO
obeticholic acid results in decreased expression of SLC25A12 mRNA
CTD
PMID:27939613
NCBI chr 3:56,097,166...56,191,841
Ensembl chr 3:56,097,269...56,192,100
G
Slc27a5
solute carrier family 27 member 5
decreases expression
ISO
obeticholic acid results in decreased expression of SLC27A5 mRNA
CTD
PMID:27939613
NCBI chr 1:73,616,556...73,627,149
Ensembl chr 1:73,616,564...73,627,172
G
Slc51a
solute carrier family 51 member A
increases expression
ISO
obeticholic acid results in increased expression of SLC51A mRNA; obeticholic acid results in increased expression of SLC51A protein
CTD
PMID:26655953 PMID:27939613
NCBI chr11:68,299,086...68,313,485
Ensembl chr11:68,299,086...68,313,485
G
Slc51b
SLC51 subunit beta
increases expression multiple interactions
ISO EXP
obeticholic acid results in increased expression of SLC51B mRNA obeticholic acid inhibits the reaction [Pyrazinamide results in decreased expression of SLC51B mRNA]
CTD
PMID:26655953 PMID:27255380 PMID:27939613
NCBI chr 8:65,931,891...65,939,953
Ensembl chr 8:65,931,890...65,940,145
G
Slco1b2
solute carrier organic anion transporter family member 1B2
multiple interactions increases expression
EXP ISO
obeticholic acid inhibits the reaction [Pyrazinamide results in decreased expression of SLCO1B2 mRNA] obeticholic acid results in increased expression of SLCO1B2 mRNA obeticholic acid results in increased expression of SLCO1B3 mRNA
CTD
PMID:27255380 PMID:27939613
NCBI chr 4:174,551,463...174,619,988
Ensembl chr 4:174,551,480...174,619,981
G
Socs2
suppressor of cytokine signaling 2
decreases expression
ISO
obeticholic acid results in decreased expression of SOCS2 mRNA
CTD
PMID:27939613
NCBI chr 7:30,006,360...30,045,161
Ensembl chr 7:30,008,578...30,043,548
G
Sod2
superoxide dismutase 2
decreases expression
ISO
obeticholic acid results in decreased expression of SOD2 mRNA
CTD
PMID:27939613
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sqstm1
sequestosome 1
multiple interactions
ISO
obeticholic acid inhibits the reaction [Dietary Fats results in decreased expression of SQSTM1 protein]
CTD
PMID:26655953
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Srebf1
sterol regulatory element binding transcription factor 1
multiple interactions decreases expression
ISO EXP
obeticholic acid inhibits the reaction [Ethanol results in increased expression of SREBF1 protein] obeticholic acid results in decreased expression of SREBF1 mRNA Obeticholic acid inhibits the reaction [ethanol increases expression of Srebf1 mRNA and protein in liver]
CTD RGD
PMID:27939613 PMID:27939985 PMID:27939985
RGD:15036816
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Srebf2
sterol regulatory element binding transcription factor 2
multiple interactions decreases expression
ISO
obeticholic acid inhibits the reaction [Dietary Fats results in increased expression of SREBF2 mRNA] obeticholic acid results in decreased expression of SREBF2 mRNA
CTD
PMID:26655953 PMID:27939613
NCBI chr 7:113,663,202...113,720,850
Ensembl chr 7:113,663,202...113,720,848
G
Sult2a1
sulfotransferase family 2A member 1
multiple interactions
ISO
obeticholic acid promotes the reaction [1-Naphthylisothiocyanate results in increased expression of SULT2A1 mRNA]
CTD
PMID:29660435
NCBI chr 1:75,451,178...75,508,113
Ensembl chr 1:74,911,100...75,508,134
G
Szrd1
SUZ RNA binding domain containing 1
increases expression
ISO
obeticholic acid results in increased expression of SZRD1 mRNA
CTD
PMID:27939613
NCBI chr 5:153,418,748...153,443,286
Ensembl chr 5:153,418,748...153,443,252
G
Tab1
TGF-beta activated kinase 1/MAP3K7 binding protein 1
decreases expression
ISO
obeticholic acid results in decreased expression of TAB1 mRNA
CTD
PMID:27939613
NCBI chr 7:111,675,829...111,707,058
Ensembl chr 7:111,686,371...111,707,058
G
Tapbp
TAP binding protein
decreases expression
ISO
obeticholic acid results in decreased expression of TAPBP mRNA
CTD
PMID:27939613
NCBI chr20:4,956,937...4,966,191
Ensembl chr20:4,956,937...4,966,181
G
Tcea2
transcription elongation factor A2
increases expression
ISO
obeticholic acid results in increased expression of TCEA2 mRNA
CTD
PMID:27939613
NCBI chr 3:168,796,244...168,804,125
Ensembl chr 3:168,796,331...168,804,116
G
Tecr
trans-2,3-enoyl-CoA reductase
decreases expression
ISO
obeticholic acid results in decreased expression of TECR mRNA
CTD
PMID:27939613
NCBI chr19:24,526,700...24,568,168
Ensembl chr19:24,541,615...24,568,168
G
Tedc1
tubulin epsilon and delta complex 1
decreases expression
ISO
obeticholic acid results in decreased expression of TEDC1 mRNA
CTD
PMID:27939613
NCBI chr 6:132,234,764...132,245,164
Ensembl chr 6:132,236,925...132,244,928
G
Tgfb1
transforming growth factor, beta 1
multiple interactions decreases expression
EXP ISO
obeticholic acid inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA] obeticholic acid results in decreased expression of TGFB1 mRNA obeticholic acid inhibits the reaction [[Dietary Fats co-treated with Dextran Sulfate] results in increased expression of TGFB1 protein]
CTD
PMID:15980055 PMID:27939613 PMID:35439472
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tgfb2
transforming growth factor, beta 2
decreases expression
ISO
obeticholic acid results in decreased expression of TGFB2 mRNA
CTD
PMID:27939613
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
G
Tgfb3
transforming growth factor, beta 3
increases expression
ISO
obeticholic acid results in increased expression of TGFB3 mRNA
CTD
PMID:27939613
NCBI chr 6:105,704,058...105,726,661
Ensembl chr 6:105,704,236...105,726,564
G
Tgfbr1
transforming growth factor, beta receptor 1
decreases expression
ISO
obeticholic acid results in decreased expression of TGFBR1 mRNA
CTD
PMID:27939613
NCBI chr 5:61,653,773...61,710,777
Ensembl chr 5:61,653,233...61,710,777
G
Timp1
TIMP metallopeptidase inhibitor 1
multiple interactions decreases expression
EXP ISO
NR0B2 protein affects the reaction [obeticholic acid inhibits the reaction [JUND protein binds to TIMP1 promoter]]; NR0B2 protein affects the reaction [obeticholic acid results in decreased expression of and results in decreased secretion of TIMP1 protein]; obeticholic acid inhibits the reaction [Carbon Tetrachloride results in increased expression of TIMP1 mRNA]; obeticholic acid results in decreased expression of and results in decreased secretion of TIMP1 protein obeticholic acid results in decreased expression of TIMP1 mRNA
CTD
PMID:15860571 PMID:27939613
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Timp2
TIMP metallopeptidase inhibitor 2
multiple interactions
EXP
obeticholic acid inhibits the reaction [Carbon Tetrachloride results in increased expression of TIMP2 mRNA]
CTD
PMID:15860571
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
G
Tjp1
tight junction protein 1
multiple interactions
ISO
obeticholic acid promotes the reaction [[Dietary Fats co-treated with Dextran Sulfate] results in increased expression of TJP1 protein]
CTD
PMID:35439472
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
G
Tk1
thymidine kinase 1
decreases expression
ISO
obeticholic acid results in decreased expression of TK1 mRNA
CTD
PMID:27939613
NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920
G
Tlr4
toll-like receptor 4
multiple interactions
ISO
obeticholic acid inhibits the reaction [[Dietary Fats co-treated with Dextran Sulfate] results in increased expression of TLR4 protein]; obeticholic acid inhibits the reaction [Methamphetamine results in increased expression of TLR4 protein]
CTD
PMID:35439472 PMID:35688268 PMID:36720452
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
multiple interactions decreases secretion
ISO EXP
NR1H4 gene mutant form inhibits the reaction [obeticholic acid inhibits the reaction [TNF results in increased expression of SELP mRNA]]; obeticholic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TNF mRNA]; obeticholic acid inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of TNF protein]; obeticholic acid inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF mRNA]; obeticholic acid inhibits the reaction [Dietary Fats results in increased expression of TNF protein]; obeticholic acid inhibits the reaction [Methamphetamine results in increased expression of TNF mRNA]; obeticholic acid inhibits the reaction [TNF results in increased expression of SELP mRNA] obeticholic acid inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] obeticholic acid results in decreased secretion of TNF protein Obeticholic acid inhibits the reaction [ethanol increases expression of Tnf protein in liver]
CTD RGD
PMID:21242261 PMID:22135065 PMID:27865854 PMID:29660435 PMID:30745416 PMID:35688268 PMID:36720452 PMID:38103844 PMID:27939985 More...
RGD:15036816
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1b
TNF receptor superfamily member 1B
increases expression
ISO
obeticholic acid results in increased expression of TNFRSF1B mRNA
CTD
PMID:27939613
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
G
Traf2
Tnf receptor-associated factor 2
decreases expression
ISO
obeticholic acid results in decreased expression of TRAF2 mRNA
CTD
PMID:27939613
NCBI chr 3:8,341,950...8,366,609
Ensembl chr 3:8,341,951...8,366,538
G
Txn1
thioredoxin 1
decreases expression
ISO
obeticholic acid results in decreased expression of TXN mRNA
CTD
PMID:27939613
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
G
Txnrd2
thioredoxin reductase 2
decreases expression
ISO
obeticholic acid results in decreased expression of TXNRD2 mRNA
CTD
PMID:27939613
NCBI chr11:82,519,996...82,568,156
Ensembl chr11:82,519,999...82,568,156
G
Tyk2
tyrosine kinase 2
decreases expression
ISO
obeticholic acid results in decreased expression of TYK2 mRNA
CTD
PMID:27939613
NCBI chr 8:19,641,881...19,667,157
Ensembl chr 8:19,641,884...19,667,044
G
Tymp
thymidine phosphorylase
decreases expression
ISO
obeticholic acid results in decreased expression of TYMP mRNA
CTD
PMID:27939613
NCBI chr 7:120,438,768...120,444,088
Ensembl chr 7:120,438,770...120,443,874 Ensembl chr 7:120,438,770...120,443,874
G
Ube2e3
ubiquitin-conjugating enzyme E2E 3
increases expression
ISO
obeticholic acid results in increased expression of UBE2E3 mRNA
CTD
PMID:27939613
NCBI chr 3:63,786,976...63,851,400
Ensembl chr 3:63,786,650...63,843,237
G
Ubxn10
UBX domain protein 10
increases expression
ISO
obeticholic acid results in increased expression of UBXN10 mRNA
CTD
PMID:27939613
NCBI chr 5:150,953,772...150,959,608
Ensembl chr 5:150,950,731...150,959,744
G
Uckl1
uridine-cytidine kinase 1-like 1
decreases expression
ISO
obeticholic acid results in decreased expression of UCKL1 mRNA
CTD
PMID:27939613
NCBI chr 3:168,674,849...168,687,513
Ensembl chr 3:168,674,849...168,698,091
G
Ugp2
UDP-glucose pyrophosphorylase 2
increases expression
ISO
obeticholic acid results in increased expression of UGP2 mRNA
CTD
PMID:27939613
NCBI chr14:95,456,330...95,497,483
Ensembl chr14:95,456,330...95,496,830
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
increases expression increases glucuronidation
ISO
obeticholic acid results in increased expression of UGT1A1 mRNA UGT1A1 protein results in increased glucuronidation of obeticholic acid
CTD
PMID:27939613 PMID:31299240
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
increases glucuronidation multiple interactions
ISO
UGT1A3 protein results in increased glucuronidation of obeticholic acid [Lapatinib results in decreased activity of UGT1A3 protein] which results in decreased glucuronidation of obeticholic acid
CTD
PMID:31299240
NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a5
UDP glucuronosyltransferase family 1 member A5
decreases expression increases glucuronidation
ISO
obeticholic acid results in decreased expression of UGT1A4 mRNA UGT1A4 protein results in increased glucuronidation of obeticholic acid
CTD
PMID:27939613 PMID:31299240
NCBI chr 9:88,762,250...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a6
UDP glucuronosyltransferase family 1 member A6
decreases expression
ISO
obeticholic acid results in decreased expression of UGT1A6 mRNA
CTD
PMID:27939613
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a9
UDP glucuronosyltransferase family 1 member A9
decreases expression
ISO
obeticholic acid results in decreased expression of UGT1A9 mRNA
CTD
PMID:27939613
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt2b7
UDP glucuronosyltransferase family 2 member B7
decreases expression
ISO
obeticholic acid results in decreased expression of UGT2B7 mRNA
CTD
PMID:27939613
NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604
G
Upb1
beta-ureidopropionase 1
decreases expression
ISO
obeticholic acid results in decreased expression of UPB1 mRNA
CTD
PMID:27939613
NCBI chr20:13,217,252...13,243,590
Ensembl chr20:13,217,258...13,243,590
G
Upp1
uridine phosphorylase 1
increases expression
ISO
obeticholic acid results in increased expression of UPP1 mRNA
CTD
PMID:27939613
NCBI chr14:83,809,495...83,829,299
Ensembl chr14:83,809,960...83,829,462
G
Upp2
uridine phosphorylase 2
increases expression
ISO
obeticholic acid results in increased expression of UPP2 mRNA
CTD
PMID:27939613
NCBI chr 3:43,273,048...43,317,417
Ensembl chr 3:43,273,048...43,317,417
G
Uroc1
urocanate hydratase 1
increases expression
ISO
obeticholic acid results in increased expression of UROC1 mRNA
CTD
PMID:27939613
NCBI chr 4:122,844,933...122,876,584
Ensembl chr 4:122,844,926...122,876,591
G
Xdh
xanthine dehydrogenase
increases expression
ISO
obeticholic acid results in increased expression of XDH mRNA
CTD
PMID:27939613
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all